Department of Obstetrics and Gynecology and Reproductive Sciences, Division of Gynecologic Specialties, University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pittsburgh, PA.
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR.
Am J Obstet Gynecol. 2019 Apr;220(4):373.e1-373.e8. doi: 10.1016/j.ajog.2019.01.212. Epub 2019 Jan 22.
Opioids are effective for the treatment of postoperative pain but can cause nausea and are associated with dependency with long-term use. Nonopioid medications such as acetaminophen offer the promise of decreasing these nondesirable effects while still providing patient comfort.
The purpose of this study was to compare intravenous acetaminophen with placebo and to evaluate postoperative pain control and opioid usage after laparoscopic hysterectomy.
We conducted a prospective double-blind randomized study with 183 patients who were assigned randomly (1:1) to receive acetaminophen or placebo (Canadian Task Force Design Classification I). Patients received either 1000 mg of acetaminophen (n=91) or a placebo of saline solution (n=92) at the time of induction of anesthesia and a repeat dose 6 hours later. Both groups self-reported pain and nausea levels preoperatively and at 2, 4, 6, 12, and 24 hours after extubation with the use of a visual analog scale with a score of 0 for no pain to 10 for highest level of pain. Patients self-reported pain, nausea, and postoperative oral opiates that were taken after discharge. All opiates were converted to milligram equivalents of oral morphine for standardization.
There were no significant differences in generalized abdominal pain at any time point postoperatively that included 2 hours (placebo 3.6±2.5 vs acetaminophen 4.4±2.5; P=.07) and up to 24 hours (placebo 3.3±2.4 vs acetaminophen 3.6±2.5; P=.28). Similar results were observed for nausea scores. There were no differences in opioid consumption at any time point including intraoperatively (placebo 4.4±3.9 vs acetaminophen 3.3±4.0; P=.06), post anesthesia care unit (placebo 10.5±10.3 vs acetaminophen 9.7±10.3; P=.59), and up to 24 hours after surgery (placebo 1.4±2.0 vs acetaminophen 1.6±2.1; P=.61). There were no differences in demographics or surgical data between groups.
There was no difference between acetaminophen and placebo groups in postoperative pain, satisfaction scores, or opioid requirements. Given the relatively high cost ($23.20 per dose in our study), lack of benefit, and available oral alternatives, our results do not support routine use during hysterectomy.
阿片类药物在治疗术后疼痛方面非常有效,但会引起恶心,并可能导致长期使用产生依赖性。非阿片类药物如对乙酰氨基酚有希望减少这些不良影响,同时仍能为患者提供舒适感。
本研究旨在比较静脉注射对乙酰氨基酚与安慰剂,并评估腹腔镜子宫切除术后的术后疼痛控制和阿片类药物使用情况。
我们进行了一项前瞻性、双盲、随机研究,共纳入 183 名患者,按 1:1 的比例随机分配(加拿大任务组设计分类 I)接受对乙酰氨基酚或安慰剂(盐水)。麻醉诱导时,患者分别接受 1000 毫克对乙酰氨基酚(n=91)或安慰剂(n=92),6 小时后重复用药。两组患者在术前、拔管后 2、4、6、12 和 24 小时使用视觉模拟量表(0 分表示无痛,10 分表示最痛)自我报告疼痛和恶心程度。患者自我报告疼痛、恶心和出院后服用的口服阿片类药物。所有阿片类药物均换算为口服吗啡的毫克当量以标准化。
术后任何时间点的一般性腹痛均无显著差异,包括术后 2 小时(安慰剂 3.6±2.5 vs 对乙酰氨基酚 4.4±2.5;P=0.07)和 24 小时(安慰剂 3.3±2.4 vs 对乙酰氨基酚 3.6±2.5;P=0.28)。恶心评分也有类似的结果。任何时间点的阿片类药物用量均无差异,包括术中(安慰剂 4.4±3.9 vs 对乙酰氨基酚 3.3±4.0;P=0.06)、麻醉后护理单元(安慰剂 10.5±10.3 vs 对乙酰氨基酚 9.7±10.3;P=0.59)和术后 24 小时(安慰剂 1.4±2.0 vs 对乙酰氨基酚 1.6±2.1;P=0.61)。两组患者的人口统计学和手术数据无差异。
在术后疼痛、满意度评分或阿片类药物需求方面,对乙酰氨基酚组与安慰剂组之间无差异。鉴于相对较高的成本(我们的研究中每剂 23.20 美元)、缺乏益处和可用的口服替代药物,我们的结果不支持在子宫切除术中常规使用。